PURPOSE: Determine the effect of PEGylation on in-vitro degradation for recombinant human Megakaryocyte Growth and Development Factor (rHuMGDF) in the neutral pH range. METHODS: Degradation products were characterized by cation-exchange HPLC, N-terminal sequencing and mass spectrometry. RESULTS: The main route of degradation was through non-enzymatic cyclization of the first two amino acids and subsequent cleavage to form a diketopiperazine and des(Ser, Pro)rHuMGDE This reaction was prevented by alkylation of the N-terminus by polyethylene glycol (PEG). CONCLUSIONS: PEGylation of proteins is commonly performed to achieve increased in-vivo circulation half-lives. For rHuMGDF, an additional advantage of PEGylation was enhanced in-vitro shelf-life stability.
PURPOSE: Determine the effect of PEGylation on in-vitro degradation for recombinant humanMegakaryocyte Growth and Development Factor (rHuMGDF) in the neutral pH range. METHODS: Degradation products were characterized by cation-exchange HPLC, N-terminal sequencing and mass spectrometry. RESULTS: The main route of degradation was through non-enzymatic cyclization of the first two amino acids and subsequent cleavage to form a diketopiperazine and des(Ser, Pro)rHuMGDE This reaction was prevented by alkylation of the N-terminus by polyethylene glycol (PEG). CONCLUSIONS: PEGylation of proteins is commonly performed to achieve increased in-vivo circulation half-lives. For rHuMGDF, an additional advantage of PEGylation was enhanced in-vitro shelf-life stability.
Authors: F J de Sauvage; P E Hass; S D Spencer; B E Malloy; A L Gurney; S A Spencer; W C Darbonne; W J Henzel; S C Wong; W J Kuang Journal: Nature Date: 1994-06-16 Impact factor: 49.962
Authors: S Lok; K Kaushansky; R D Holly; J L Kuijper; C E Lofton-Day; P J Oort; F J Grant; M D Heipel; S K Burkhead; J M Kramer Journal: Nature Date: 1994-06-16 Impact factor: 49.962
Authors: T D Bartley; J Bogenberger; P Hunt; Y S Li; H S Lu; F Martin; M S Chang; B Samal; J L Nichol; S Swift Journal: Cell Date: 1994-07-01 Impact factor: 41.582
Authors: K Kaushansky; V C Broudy; A Grossmann; J Humes; N Lin; H P Ren; M C Bailey; T Papayannopoulou; J W Forstrom; K H Sprugel Journal: J Clin Invest Date: 1995-09 Impact factor: 14.808
Authors: T R Ulich; J del Castillo; S Yin; S Swift; D Padilla; G Senaldi; L Bennett; J Shutter; J Bogenberger; D Sun Journal: Blood Date: 1995-08-01 Impact factor: 22.113